DK29490D0 - Antistof mod angiogenin og farmaceutisk praeparat indeholdende et saadant antistof - Google Patents

Antistof mod angiogenin og farmaceutisk praeparat indeholdende et saadant antistof

Info

Publication number
DK29490D0
DK29490D0 DK029490A DK29490A DK29490D0 DK 29490 D0 DK29490 D0 DK 29490D0 DK 029490 A DK029490 A DK 029490A DK 29490 A DK29490 A DK 29490A DK 29490 D0 DK29490 D0 DK 29490D0
Authority
DK
Denmark
Prior art keywords
antibody
pharmaceutical preparations
preparations containing
angiogenin
antibody against
Prior art date
Application number
DK029490A
Other languages
English (en)
Other versions
DK29490A (da
Inventor
James W Fett
Bert L Vallee
Edward M Alderman
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Publication of DK29490D0 publication Critical patent/DK29490D0/da
Publication of DK29490A publication Critical patent/DK29490A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK029490A 1987-08-06 1990-02-05 Antistof mod angiogenin og farmaceutisk praeparat indeholdende et saadant antistof DK29490A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/083,231 US4853219A (en) 1987-08-06 1987-08-06 Antibodies to angiogenin: immunotherapeutic agents
PCT/US1988/002590 WO1989000862A1 (en) 1987-08-06 1988-08-05 Antibodies to angiogenin: immunotherapeutic agents

Publications (2)

Publication Number Publication Date
DK29490D0 true DK29490D0 (da) 1990-02-05
DK29490A DK29490A (da) 1990-03-30

Family

ID=22177021

Family Applications (1)

Application Number Title Priority Date Filing Date
DK029490A DK29490A (da) 1987-08-06 1990-02-05 Antistof mod angiogenin og farmaceutisk praeparat indeholdende et saadant antistof

Country Status (13)

Country Link
US (1) US4853219A (da)
EP (1) EP0436526B1 (da)
JP (1) JPH02504512A (da)
KR (1) KR920005691B1 (da)
AT (1) ATE133075T1 (da)
AU (1) AU618024B2 (da)
CA (1) CA1341425C (da)
DE (1) DE3854926T2 (da)
DK (1) DK29490A (da)
ES (1) ES2015349A6 (da)
GR (1) GR1000430B (da)
PT (1) PT88314A (da)
WO (1) WO1989000862A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5520914A (en) * 1987-08-06 1996-05-28 President And Fellows Of Harvard College Antibodies to angiogenin: immunotherapeutic agents
FR2623509B1 (fr) * 1987-11-19 1990-04-20 Centre Nat Rech Scient Proteine de 17 kd a action angiogenique, son procede d'isolement a partir de lait de mammiferes, compositions therapeutiques la contenant, procede de detection et/ou de dosage et reactifs immunologiques de detection et de dosage des angiogenines de mammiferes, de leurs homologues et de leurs fragments
US6929907B2 (en) * 1999-12-31 2005-08-16 North Carolina State University Methods and compositions for determining the purity of chemically synthesized nucleic acids
RU2197263C1 (ru) * 2001-05-16 2003-01-27 Московский областной научно-исследовательский клинический институт Способ лечения ран и язвенных дефектов
WO2002100899A2 (de) 2001-06-13 2002-12-19 Osteopep-Pharma Gmbh Arzneimittel zur behandlung von tumoren und deren metastasen unter verwendung eines bindemoleküls gegen das bone-sialoprotein
CA2814598A1 (en) * 2005-09-12 2007-03-22 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer
AU2007246921A1 (en) * 2006-04-10 2007-11-15 Fusion Antibodies Limited Therapy targeting Cathepsin S

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4229532A (en) * 1978-12-29 1980-10-21 Monsanto Company Production of tumor angiogenesis factor by cell culture
US4229531A (en) * 1978-12-29 1980-10-21 Monsanto Company Production of tumor angiogenesis factor by cell culture
US4273871A (en) * 1980-03-03 1981-06-16 Monsanto Company Production of angiogenic factor by cell culture
DE3110560A1 (de) * 1981-03-18 1982-10-14 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen "angiotropine der leukozyten und des entzuendungsgewebes: eine neue klasse natuerlicher chemotropischer mitogene fuer das richtungswachstum von blutgefaessen und zur neovaskularisierung von geweben"
GB2131294B (en) * 1982-11-30 1987-06-10 Univ Manchester Low molecular weight angiogenic factor
US4529590A (en) * 1982-12-27 1985-07-16 Leveen Robert F Production of angiogenetic factor
US4503038A (en) * 1983-02-25 1985-03-05 The Regents Of The University Of California Extracellular nonmitogenic angiogenesis factor and method of isolation thereof from wound fluid
US4699788A (en) * 1984-08-20 1987-10-13 Trustees Of Boston University Angiogenic factor methods of extraction and method for producing angiogenesis
US4727137A (en) * 1985-04-17 1988-02-23 President And Fellows Of Harvard College Purified protein having angiogenic activity and methods of preparation
IL81650A0 (en) * 1986-02-24 1987-09-16 Robapharm Ag Purified human angiogenic factor,method for its preparation and pharmaceutical preparations

Also Published As

Publication number Publication date
EP0436526A1 (en) 1991-07-17
US4853219A (en) 1989-08-01
AU2316688A (en) 1989-03-01
GR1000430B (el) 1992-07-30
KR920005691B1 (ko) 1992-07-13
CA1341425C (en) 2003-03-18
WO1989000862A1 (en) 1989-02-09
DK29490A (da) 1990-03-30
AU618024B2 (en) 1991-12-12
PT88314A (pt) 1989-06-30
EP0436526A4 (en) 1990-08-20
ATE133075T1 (de) 1996-02-15
JPH02504512A (ja) 1990-12-20
DE3854926D1 (de) 1996-02-29
ES2015349A6 (es) 1990-08-16
KR890701130A (ko) 1989-12-19
EP0436526B1 (en) 1996-01-17
DE3854926T2 (de) 1996-05-30

Similar Documents

Publication Publication Date Title
NO883664L (no) Fremgangsmaate og innretning for bearbeiding av smeltet glass.
TW224053B (da)
NO884190D0 (no) Fremgangsmaate og innretning for ekstrudering av plastroer.
NO302176B1 (no) Fremgangsmåte for fremstilling av et monoklonalt antistoff og et antigen
GB1356229A (en) Method for isolation of antithrombin from animal material
NO885382D0 (no) Fremgangsmaate og anordning for aktivering av et produksjonsroer-fremfoert perforeringsapparat.
NO794062L (no) Fremgangsmaate og innretning for ultralydundersoekelse av roer o.l.
DK29490D0 (da) Antistof mod angiogenin og farmaceutisk praeparat indeholdende et saadant antistof
NO871396D0 (no) Fremgangsmaate og innretning for termomagnetisk kopiering av magnetbaand.
AU525403B2 (en) Purified antigen
NO162760C (no) Fremgangsmaate og anordning for produksjon av glassfilamenter.
NO884929L (no) Fremgangsmaate og anordning for aa bestemme dybde av perforeringer.
DK21586A (da) Antigener og antistoffer samt praeparater indeholdende disse
NO885658D0 (no) Retrovirusekspresjonsvektorer og fremgangsmaater for fremstilling av hbv-antigener.
DE2964390D1 (en) Isolation of hepatitis be antigen
NO903890L (no) Fremgangsmaate og innretning for dannelse av et slukkesperresignal for utkoblbare effekthalvledere.
NO881905D0 (no) Monoklonalt antistoff til selektiv immunologisk bestemmelse av intakt prokollagen peptid (type iii) og prokollagen (type iii) i kroppsvaesker.
NO865280D0 (no) Anordning og fremgangsmaate for bestemmelse av orienteringen av sprekker i geologisk formasjon.
NO881502L (no) Rekombinante htlv-111-proteiner og anvendelser av disse.
DK265288D0 (da) Oximino-ether-forbindelser og fremgangsmaade til fremstilling deraf
SU534429A1 (ru) Магнитооптическое стекло
Luksamijarulkul et al. Enzyme-linked immunosorbent assay for early detection of whooping cough
NO873664D0 (no) Framgangsmaate for paafoering og fastgjoering av foeringsbaand.
NO891520L (no) Kledningselement med naturstenplate og fremgangsmaate for fremstilling av et slikt element.
SU1210573A1 (ru) Способ сейсмической разведки и устройство для его осуществления

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment